Roche (OTCQX:RHHBY) says the U.S. Food and Drug Administration issued an emergency use authorization for its new Elecsys antibody test to help determine if people have been infected with the coronavirus.
Roche says the new test, which has a specificity
greater than 99.8%, is designed to help determine if a patient has been
exposed to the SARS-CoV-2 virus and if the patient has developed
antibodies against the virus.
The company says it has already started shipping
the test to laboratories globally and will ramp up production capacity
to high double-digit millions per month for countries accepting the CE
mark as well as the U.S.
https://seekingalpha.com/news/3567991-roches-covidminus-19-antibody-test-gets-fda-emergency-use-approval
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.